Radioimmunotherapy of at-211-labeled anti-fibroblast growth factor receptor 4 (fgfr4) antibody is a promising treatment for peritoneal dissemination of gastric cancer: in immunocompetent mice study

GASTROENTEROLOGY(2023)

引用 0|浏览8
暂无评分
关键词
gastric cancer,fgfr4,radioimmunotherapy,peritoneal dissemination,antibody,anti-fibroblast
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要